Search

everythinglearnresearchcommunity

for

Search:↓

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The hot-wire hair removal device is no better than shaving.

Biologics for severe asthma have known side effects, but some new risks need more study.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Platelet-rich plasma therapy may have benefits and is generally safe, but more research is needed to confirm its effectiveness and safety.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.